Qilu Pharmaceuticals " O nitrogen flat mouth solution film" is about to be approved for the market

Recently, Qilu Pharmaceuticals according to the chemical drug class 2.2 declared O nitrogen flat mouth solution membrane application (acceptance number: JXHS1800028, CXHS1900029) is in the "in the approval" stage, is expected to be approved by NMPA in the near future.
became the second approved enterprise of this dosage form after Jiangsu Haussen.
, originally researched by Lilly and first listed in China in 1998, is used to treat schizophrenia, moderate to severe mania and bipolar disorder.
Qilu's O nitrogen flat tablets and mouth collapse tablets have passed the consistency evaluation, its O nitrogen flat tablets in the "4 plus 7" band procurement expansion with 2.48 yuan / piece price finalist, its O nitrogen flat flat tablets with 6.3 yuan / piece price into the third batch of collection catalog.
approval of the oral instant film will be another heavyweight product in the field of the central nervous system in its layout.
Ziruo nitrogen flat-mouth solution was approved based on a bioethic study of two preparations in healthy adult adult subjects based on the bioethicity study of the product and the participating preparation O nitrogen flat-mouth collapse tablets (repule, specification: 5 mg; Catalent UK Swindon Zydis Ltd.) in a healthy adult subject's empty stomach/after-meal state (clinical study registration number: CTR20190536).
Pharmaceutical Rubik's Cube PharmaGo Oral Instant Membrane (OFDF) is a new drug delivery system, that is, a certain dose of chemicals or Chinese medicine extract active ingredients fixed on the denatured starch and collage made of film chips, its size, shape, thickness similar to stamps, with small size, light quality, easy to take, no over-effect advantages, especially for children, the elderly, swallowing difficulties patients.
。